Abstract: |
Several ETS transcription factors, including ELF4/MEF, can function as oncogenes in murine cancer models and are overexpressed in human cancer. We found that Elf4/Mef activates Mdm2 expression; thus, lack of or knockdown of Elf4/Mef reduces Mdm2 levels in mouse embryonic fibroblasts (mef's), leading to enhanced p53 protein accumulation and p53-dependent senescence. Even though p53 is absent in Elf4<sup>-/-</sup> p53<sup>-/-</sup> mef's, neither oncogenic H-Ras<sub>V12</sub> nor c-myc can induce transformation of these cells. This appears to relate to the INK4a/ARF locus; both p19<sup>ARF</sup> and p16 are increased in Elf4<sup>-/-</sup> p53<sup>-/-</sup> mef's, and expression of Bmi-1 or knockdown of p16 in this context restores H-Ras<sup>V12</sup>-induced transformation. Thus, ELF4/MEF promotes tumorigenesis by inhibiting both the p53 and p16/Rb pathways. Copyright © 2009, American Society for Microbiology. All Rights Reserved. |
Keywords: |
cancer survival; controlled study; human tissue; protein expression; survival rate; unclassified drug; dna-binding proteins; proto-oncogene proteins; nonhuman; mouse; animals; mice; mice, knockout; animal tissue; cells, cultured; gene overexpression; protein p16; animal experiment; animal model; gene locus; protein p53; oncogene h ras; carcinogenesis; transcription factors; cell transformation, neoplastic; nuclear proteins; gene expression regulation; promoter regions, genetic; murinae; fibroblast; fibroblasts; tumor suppressor protein p53; senescence; protein p19; cyclin-dependent kinase inhibitor p16; genes, ras; oncogene c myc; malignant transformation; retinoblastoma protein; bmi1 protein; repressor proteins; cell aging; protein mdm2; transcription factor ets; proto-oncogene proteins c-mdm2; protein elf4
|